DART Study: A phase II randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC): Results from Part 1 Meeting Abstract
| Authors: | Voss, M. H.; Plimack, E. R.; Rini, B. I.; Atkins, M. B.; Alter, R.; Bhatt, R. S.; Beck, J. T.; Pappas, K. M.; Wilson, D.; Zhang, X. S.; Sherman, M. L.; Pandya, S. S. |
| Abstract Title: | DART Study: A phase II randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC): Results from Part 1 |
| Meeting Title: | 2015 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2015 Feb 26-28 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-03-01 |
| Language: | English |
| ACCESSION: | WOS:000356886700404 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.7_suppl.407 |
| Notes: | Meeting Abstract: 407 -- Source: Wos |
